Table 1.
Comp. | Activity IC50 (μM)a |
Activity IC50 (μM)a |
Activity IC50 (μM)a |
Toxicity IC50/72 h (μM) Vero cell |
||||||
---|---|---|---|---|---|---|---|---|---|---|
Arequipa strain |
SN3 strain |
Tulahuen strain |
||||||||
E/72 h | A/72 h | T/24 h | E/72 h | A/72 h | T/24 h | E/72 h | A/72 h | T/24 h | ||
BZN | 16.86 ± 1.81 | 8.25 ± 0.72 | 12.35 ± 1.14 | 36.51 ± 2.44 | 16.62 ± 1.46 | 36.09 ± 3.12 | 19.72 ± 1.75 | 9.96 ± 0.84 | 15.09 ± 1.30 | 80.35 ± 7.08 |
AS-48 | 0.76 ± 0.11 | 0.99 ± 0.13 | 0.17 ± 0.04 | 1.16 ± 0.18 | 6.81 ± 0.89 | 0.11 ± 0.02 | 0.82 ± 0.11 | 1.98 ± 0.22 | 0.19 ± 0.03 | 93.06 ± 5.67 |
IC50 = concentration (μM) required to inhibit 50% population, calculated using GraphPad Prism 6. Results are averages of three separate determinations ± standard deviation. E, epimastigote forms. A, amastigote forms. T, trypomastigote forms.